Companies are increasingly looking for Generative AI (GenAI) to uncover insights, boost efficiencies, and unlock value across their organizations. GenAI presents an unparalleled opportunity with its ability to synthesize vast amounts of data, whether structured or unstructured , and in multiple formats beyond simple text. But how do companies ensure their GenAI initiatives evolve beyond mere experimentation?
Axtria, a leader in data, analytics and AI products and services for life sciences, gathered more than 30 top executives from the world’s largest pharmaceutical companies to discuss GenAI. We sat down with them during our highly anticipated Axtria Ignite annual event to plot out a roadmap for enterprise-level value creation. And what we quickly discovered is that this framework has the potential to transform any industry, not just life sciences.
This collaboration identified seven steps that can easily apply to any line of business or commercial enterprise. This GenAI roadmap helps avoid the struggles …